These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effects on the human fibrinolytic system of prolonged intravenous infusion of high doses of Complamin (xantinol nicotinate). Bouvier CA, Berthoud S. Helv Med Acta; 1968 Mar; 34(2):170-86. PubMed ID: 4232105 [No Abstract] [Full Text] [Related]
5. [Treatment of adnexitis with complamin]. Steichele DF, Herschlein HJ, Bernlehr R, Kunz S. Med Welt; 1971 Mar 13; 11():439-41. PubMed ID: 5092907 [No Abstract] [Full Text] [Related]
13. Possibilities of development of fibrinolytic activity with new and projected agents. Cliffton EE. Angiologica; 1968 Mar 13; 5(2):146-60. PubMed ID: 4232515 [No Abstract] [Full Text] [Related]
17. [Therapy of hyperlipemia using xantinol-nicotinate]. Möller-Hardenack B. Med Monatsschr; 1973 Aug 13; 27(8):370-2. PubMed ID: 4756297 [No Abstract] [Full Text] [Related]